Parkinson Disease: all 4,583 studies
Page 35 of 46. Open to participants first (1,097), then studies with results posted, then the rest; newest registration first within each.
- Serotonin and AmyloidopathyCompletedNCT02895932Not applicable
- Lipiflow Versus Warm Compresses in Parkinson's DiseaseWithdrawnNCT02894658Not applicable
- Evaluation of Directional Recording and Stimulation Using spiderSTNTerminatedNCT02894567Not applicable
- Action-effect Anticipation in Patients With Parkinson's Disease : A Study of the Sensory Attenuation Marker.TerminatedNCT02894333
- Dynamic ASPECTS of Internal PRE-ACTIVATION of Effects Sensors of Voluntary ACTION in PARKINSON's DiseaseCompletedNCT02894320
- Psychiatry Study: Parkinson DiseaseCompletedNCT02893449Not applicable
- A Rehabilitative Approach in Patients With Parkinson's DiseaseCompletedNCT02891473Not applicable
- The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's DiseaseTerminatedNCT02885285Not applicable
- Impact of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson DiseaseCompletedNCT02885194Not applicable
- Parkinson's Repository of Biosamples and Network Datasets (Tracking Parkinson's)CompletedNCT02881099
- Oxidative Stress and Apoptosis of Energy Metabolism by Deferiprone From the Circulating LymphocytesCompletedNCT02880033Not applicable
- TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's DiseaseCompletedNCT02879136Early Phase 1
- Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's DiseaseWithdrawnNCT02875041Not applicable
- Vaccination Uptake (VAX) in PDCompletedNCT02874274Not applicable
- Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's DiseaseCompletedNCT02874261Not applicable
- Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior DisorderTerminatedNCT02871427Phase 2
- Compensation Mechanisms in Parkinson's DiseaseCompletedNCT02869945Not applicable
- Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)CompletedNCT02864004Phase 3
- COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICECompletedNCT02860338
- Validation of a Diagnostic Self-assessment Scale Non-motor Fluctuations at the Parkinson's PatientCompletedNCT02859805
- Timing of Acute Palliative Care Consultation in Critically Ill PatientsStatus unknownNCT02858778Not applicable
- A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson PatientsWithdrawnNCT02857244Phase 2
- A Training of the Rhythmic Skills With a Serious Game to Improve Gait and Cognitive Abilities in Parkinson's DiseaseSuspendedNCT02855710Not applicable
- Prediction of Dementia in Parkinson's Disease by Measuring Cerebral Metabolism With PET ScanStatus unknownNCT02855021Not applicable
- Efficacy and Safety of Opicapone in Clinical PracticeCompletedNCT02847442Phase 4
- Memory for Action in Neurological PatientsTerminatedNCT02844855Not applicable
- RQ-00000010 for Gastroparesis and Constipation in Parkinson's DiseaseCompletedNCT02838797Phase 1
- Diagnosis of PD and PD Progression Using DWICompletedNCT02837172
- Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease PatientsCompletedNCT02834507Phase 2
- Evaluation of Bilateral Gamma Knife Thalamotomy in Patients Presenting With Severe Essential TremorCompletedNCT02827955Not applicable
- Telemedicine Program in Parkinson's Disease (TELEPARK)Status unknownNCT02827812Not applicable
- Feasibility and Optimization of a Cognitive Intervention for Parkinson DiseaseCompletedNCT02826785Not applicable
- Evaluation of Clinical Perfectionism in Parkinson DiseaseCompletedNCT02824367Not applicable
- Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior DisorderCompletedNCT02824341Not applicable
- Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIMTerminatedNCT02823158Not applicable
- One-year Follow-up of Iron in Basal Ganglia - R2*: a Biomarker of Parkinson's Disease Progression?Status unknownNCT02816645Not applicable
- Evaluation of a Personalized Physical Activity Coaching Program in Parkinson's DiseaseStatus unknownNCT02816619Not applicable
- Efficacy of Ethnodyne Visio in Parkinson's DiseaseCompletedNCT02815800Not applicable
- Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry ParadigmCompletedNCT02814201
- A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) TabletsCompletedNCT02812394Phase 1
- Effect of L-Dihydoxyphenylserine on Locomotion, Postural Stability, and Fall Risk Reduction in Parkinson DiseaseStatus unknownNCT02812147Phase 2
- Orthotics and Parkinson's Disease: The Acute and Long-term Effects of Increased Somatosensory FeedbackStatus unknownNCT02809391Not applicable
- Virtual Reality in Parkinson DiseaseCompletedNCT02807740Not applicable
- A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)CompletedNCT02807675Phase 1
- PET/MR Imaging in Patients With Short and Long Standing Parkinson's DiseaseStatus unknownNCT02801110
- New Approaches in MRI at 3T Dedicated to Targeting Subthalamic Nucleus on Parkinsonian PatientsCompletedNCT02800460Not applicable
- Comparison of Two Rehabilitation Programs in Patients With Mild to Moderate Parkinson's Disease.CompletedNCT02797496Not applicable
- Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography.Status unknownNCT02796040Not applicable
- Deep Brain Stimulation and Parkinson's DiseaseCompletedNCT02795663Early Phase 1
- Identification of Clinically Relevant Markers of Deep Brain Stimulation Electrode ImpedanceCompletedNCT02794233Not applicable
- Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson DiseaseStatus unknownNCT02789592Phase 2
- Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's DiseaseCompletedNCT02787590Phase 2
- How Does STN-DBS Influence Emotional Conflict Decision in Parkinson's Disease: a EEG StudyCompletedNCT02786680Not applicable
- Non Motors Aspects in De Novo Parkinson's DiseaseStatus unknownNCT02786667Phase 3
- Virtual Reality Effects on Functional Capacity and Quality of Life of People With Parkinson's DiseaseCompletedNCT02786433Not applicable
- Pilot Study to Evaluate ActiMyo Measured Activity in Parkinson Disease Patients & Healthy VolunteersCompletedNCT02785978Not applicable
- Determining Clinical Profile of Parkinson's Disease Among Egyptian PopulationStatus unknownNCT02785510
- Effects of Resistant Starch on Bowel Habits, Fecal Short Chain Fatty Acids and Gut Microbiota in Parkinson DiseaseCompletedNCT02784145Not applicable
- Investigating Central Mechanisms of Overactive Bladder in Adults With Parkinson's DiseaseCompletedNCT02783014
- A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor FluctuationsWithdrawnNCT02782481Phase 3
- Parkinsonian Brain Repair Using Human Stem CellsStatus unknownNCT02780895Phase 1
- Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/BenserazideCompletedNCT02778594Phase 1
- Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome MeasuresStatus unknownNCT02777060Not applicable
- Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal SymptomsCompletedNCT02775591Phase 4
- Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/CarbidopaCompletedNCT02774564Phase 1
- Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202CompletedNCT02772627Phase 1
- Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and MetabolitesCompletedNCT02772614Phase 1
- Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ONCompletedNCT02769793Phase 4
- Predictors of Motor Progression in Parkinson's DiseaseCompletedNCT02769039
- Monitoring Brain Waves in Response to Visual and/or Auditory Stimulation in Parkinson's Disease PatientsStatus unknownNCT02768896Not applicable
- Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's DiseaseStatus unknownNCT02768077Phase 4
- SudoScan as a Biomarker of Parkinson's DiseaseCompletedNCT02767037Not applicable
- Automated Deep Brain Stimulation Programming Using Functional MappingStatus unknownNCT02765282Not applicable
- A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's DiseaseCompletedNCT02764892Phase 1
- Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)CompletedNCT02764125Phase 2
- Effect of Body Suspension and Tilting Exercises in Parkinson's DiseaseCompletedNCT02763891Not applicable
- Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)CompletedNCT02763852Phase 1
- Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)CompletedNCT02763839Phase 1
- Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic and Pharmacodynamic Profile of BIA 3-202CompletedNCT02763800Phase 1
- Safety, Tolerability, Pharmacokinetics (Including Food Interaction), and Pharmacodynamics of BIA 3-202CompletedNCT02763787Phase 1
- Deep Brain Stimulation (DBS) of the Nucleus Basalis of Meynert (NbM) in Patients With Parkinson's DiseaseStatus unknownNCT02763397Not applicable
- Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian PatientsCompletedNCT02763137Phase 2
- Expanded Access of Pimavanserin for Patients With PD PsychosisApproved for marketingNCT02762591
- Biomarkers in Neural DisordersCompletedNCT02761707
- Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA PatientsWithdrawnNCT02758730Phase 1
- Impact of Rehabilitation in Quality of Life in PDCompletedNCT02756676Not applicable
- Parkinsonics: A Controlled Study of Group Singing in Parkinson DiseaseCompletedNCT02753621Phase 2
- Dysarthria in Parkinson's Disease: Lusophony vs. Francophony ComparisonStatus unknownNCT02753192Not applicable
- Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.CompletedNCT02750982Not applicable
- Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative ProcessesCompletedNCT02749214
- Continuous Behavior Assessment of the Effects of a Physical Therapy Program for Patients With Parkinson's DiseaseStatus unknownNCT02745171Not applicable
- Development of Software to Provide the SpeechVive Device Via the InternetCompletedNCT02744911Not applicable
- Levodopa Benserazide Generic Formulation Versus the OriginatorCompletedNCT02741947Phase 4
- Exercise and Transcranial Magnetic Stimulation: Increasing Brain Plasticity in Parkinson's DiseaseCompletedNCT02741765Not applicable
- MENTAL PRACTICE IN MOTOR LEARNING OF BRUSHING AND PARKINSON DISEASECompletedNCT02738528Not applicable
- Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear PalsyCompletedNCT02734485Not applicable
- Acupuncture as Adjuvant Therapy for Sleep Disorders in Parkinson's DiseaseCompletedNCT02731677Not applicable
- The Effects of Treadmill Training With Visual and Auditory Cues on Gait Parameters in Parkinsonian Patients in Advanced Stages of Disease.Status unknownNCT02731599Not applicable
- Concurrent DBS Local Field Potential Analysis and Stimulation in a Closed-Loop Neuromodulation DeviceWithdrawnNCT02731365Not applicable
- Effectiveness of Intensive Rehabilitation in Advanced Stages of Parkinson's Disease.Status unknownNCT02731170Not applicable